Merck (MRK) Tops Q1 EPS by 14c, Beats on Revenue; Offers FY24 Guidance
Tweet
Share
E-mail
Get Alerts MRK Hot Sheet
Price: $125.37 -2.44%
Revenue Growth %: +3.5%
Financial Fact:
Equity income from affiliates: -2.5B
Today's EPS Names:
CRMT, FOMI, FLES, More
Revenue Growth %: +3.5%
Financial Fact:
Equity income from affiliates: -2.5B
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Merck (NYSE: MRK) reported Q1 EPS of $2.07, $0.14 better than the analyst estimate of $1.93. Revenue for the quarter came in at $15.8 billion versus the consensus estimate of $15.22 billion.
GUIDANCE:
Merck sees FY2024 EPS of $8.53-$8.65, versus the consensus of $8.56. Merck sees FY2024 revenue of $63.1-64.3 billion, versus the consensus of $63.8 billion.
For earnings history and earnings-related data on Merck (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck (MRK) PT Raised to $155 at Scotiabank
- AeroVironment (AVAV) Tops Q4 EPS by 36c
- Greenbrier Cos. (GBX) Reports In-Line Q3 EPS
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
